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Abstract
Background: National electronic health records (EHR) are increasingly used for research but identifying disease cases is
challenging due to differences in information captured between sources (e.g. primary and secondary care). Our objective
was to provide a transparent, reproducible model for integrating these data using atrial fibrillation (AF), a chronic condition
diagnosed and managed in multiple ways in different healthcare settings, as a case study.
Methods: Potentially relevant codes for AF screening, diagnosis, and management were identified in four coding systems:
Read (primary care diagnoses and procedures), British National Formulary (BNF; primary care prescriptions), ICD-10
(secondary care diagnoses) and OPCS-4 (secondary care procedures). From these we developed a phenotype algorithm via
expert review and analysis of linked EHR data from 1998 to 2010 for a cohort of 2.14 million UK patients aged $30 years.
The cohort was also used to evaluate the phenotype by examining associations between incident AF and known risk factors.
Results: The phenotype algorithm incorporated 286 codes: 201 Read, 63 BNF, 18 ICD-10, and four OPCS-4. Incident AF
diagnoses were recorded for 72,793 patients, but only 39.6% (N= 28,795) were recorded in primary care and secondary care.
An additional 7,468 potential cases were inferred from data on treatment and pre-existing conditions. The proportion of
cases identified from each source differed by diagnosis age; inferred diagnoses contributed a greater proportion of younger
cases (#60 years), while older patients ($80 years) were mainly diagnosed in SC. Associations of risk factors (hypertension,
myocardial infarction, heart failure) with incident AF defined using different EHR sources were comparable in magnitude to
those from traditional consented cohorts.
Conclusions: A single EHR source is not sufficient to identify all patients, nor will it provide a representative sample.
Combining multiple data sources and integrating information on treatment and comorbid conditions can substantially
improve case identification.
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Introduction
One of the major challenges presented by the increasing use of
electronic health record (EHR) data for research is the develop-
ment of strategies for reliably identifying disease cases [1–4].
Hripcsak and Albers [5] argue that in order to improve the
extraction of disease information from this type of data:
…[W]e need a better understanding of the EHR. The EHR
is not a direct reflection of the patient and physiology, but a
reflection of the recording process inherent in healthcare with
noise and feedback loops. We must study the EHR as an
object in itself, as if it were a natural system.(p. 119)
This recommendation is particularly relevant to identification of
chronic conditions in which patients may have multiple interac-
tions with primary and secondary care, and undergo assessments
and diagnostic tests, before ultimately receiving a diagnosis. Even
after diagnosis, patients may receive follow-up care such as
monitoring, prescriptions, or other medical interventions [6].
Consequently, one EHR data source rarely covers the full patient
journey; usually data from different record sources (e.g. primary,
secondary, and tertiary care; medication prescription and
dispensing; mortality data) must be integrated to obtain a complete
picture [7]. However, these data also encompass variation in
patient measurement that may be context-dependent and thus
effective integration requires an exploration of what is recorded in
the EHR in relation to a particular condition, and how this
compares to expectations based upon guidelines and preconcep-
tions about clinical practice [4,8,9].
To highlight the challenges and complexities of identifying onset
of a chronic condition in linked national EHR data, and how these
can inform the development of strategies for identifying patients,
we present a case study of atrial fibrillation (AF) using national
linked EHR and administrative health data from the English
National Health Service (NHS). AF is the most common cardiac
arrhythmia, associated with increased risk of stroke, heart failure
(HF), and premature mortality [10,11]. It presents many
important challenges that may be encountered when developing
strategies for case identification, or phenotypes, in EHR data
including variability in symptoms and signs, different coding
strategies and treatment options, and changes in clinical practice
(for more in-depth discussion see [12]).
Clinical context of atrial fibrillation
Onset of AF often precedes diagnosis considerably; patients may
be asymptomatic or experience paroxysmal AF (characterized by
irregular, sudden symptoms) and clinical signs, such as irregular
pulse, may be episodic. AF may also be diagnosed when a patient
is admitted to hospital for another, potentially unrelated,
condition. UK diagnostic guidelines and those from the European
Society of Cardiology (ESC) recommend pulse palpation followed
by an electrocardiogram if an irregular pulse is detected [13,14].
Opportunistic screening of patients over the age of 65 is
recommended by the ESC, but not by North American
organisations [15].
Confirming an AF diagnosis does not necessarily simplify
documentation as recording and treatment may differ between
primary and secondary care, which use different coding systems
with different levels of granularity. Read codes, a subset of the
Systematic Nomenclature Of Medicine - Clinical Terms
(SNOMED-CT) clinical terminology, are used in primary care
and permit specification of disease subtypes and differentiation of
AF from atrial flutter. In contrast, the International Classification
of Disease – 10th revision (ICD-10) terminology used in secondary
care has one term for all categories. Treatment varies between
patients depending upon symptoms, age and other clinical
characteristics, and clinical context. Currently, most patients
receive anti-thrombotic treatment to reduce stroke risk, although
drugs for rate or rhythm control, and procedures such as
cardioversion or catheter ablation, may also be used [14].
AF diagnostic and treatment practices have changed substan-
tially over the last 10–15 years. This is due to increasing awareness
of AF and recognition that, at least in the UK, it is more likely to
be subject to under, rather than over, diagnosis [16,17]. Policy
initiatives have been introduced in the UK to address this
including: the 2004 Quality and Outcomes Framework (QOF),
which financially rewards general practitioners for implementing
treatment plans for chronic conditions, including AF [18]; the
2006 UK National Institute for Health and Care Excellence
guidelines for AF diagnosis and management [19]; the English
NHS Commissioning for Quality and Innovation (CQUIN)
scheme, introduced in 2009 to provide financial incentives for
quality improvements. Thus there may be temporal differences in
coding practices for AF.
Identification of patients with atrial fibrillation
A consistent approach to integrating EHR and administrative
health data to identify AF will facilitate transparent and
reproducible research, but currently no universal method exists.
Previous UK EHR studies have focused on primary care [20–23],
but other studies used secondary care data. We reviewed research
on AF risk factors and found substantial variation in the data
sources used to identify AF cases; 21 of 27 studies identified used
EHR data, with two using primary care [24,25], 15 using
secondary care [26–40], and four using both [41–44]. However,
many researchers are developing strategies for integrating EHR
data for research and defining EHR phenotypes [2,45–51]. The
USA-based eMERGE Consortium have developed an AF
phenotype algorithm [52], but this was created for data from
nine health care providers actively participating in research and
focuses on clinical notes and electrocardiogram impressions. As
these data are not available on a large scale to researchers in the
UK, and elsewhere, using data from nationalised health services,
our aims were to develop an understanding of EHR data relating
to AF, and to use this to develop a phenotype algorithm applicable
to linked, nationally collected data.
Thus we describe the development of the ClinicAl disease
research using Linked Bespoke studies and Electronic Records
(CALIBER) AF phenotype and use this to demonstrate how
exploration of recording patterns in multiple data sources can
inform the development of disease case identification strategies for
EHR data. We investigated whether EHR data beyond diagnosis
codes could be leveraged to refine date of disease onset; whether
cases could be inferred on the basis of medical treatment; and
whether changes in health care policy may have affected data
collection. We evaluated the face validity of the phenotype by
testing for associations with known risk factors. The strategies used
and lessons learned are broadly applicable to all EHR phenotype
development, particularly where the aim is to identify disease cases
for longitudinal research.
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Materials and Methods
Study population and linked electronic records
Anonymised patients were selected from the CALIBER cohort,
which includes linked data from: (1) primary care EHR data:
diagnoses coded using the Read system by general practitioners
during consultation or by practice administrators from hospital
discharge letters (from the Clinical Practice Research Datalink)
and prescriptions; (2) secondary care administrative records:
diagnoses and procedures recorded using the ICD terminology
and Office of Population Censuses and Surveys Classification of
Interventions and Procedures (OPCS-4, comparable to the
American Medical Association Current Procedural Terminology
medical classification system) by audit nurses after patient
admission by abstracting data from hospital records (from Hospital
Episode Statistics); (3) administrative mortality data from death
certificates where cause(s) of death are recorded by a doctor and
ICD-9 and ICD-10 codes added by trained non-clinical coders
(from UK Office of National Statistics; ONS); (4) small-area
patient social deprivation information from multiple administra-
tive data sets (from ONS) [12]. CALIBER was approved by the
Lewisham Local Research Ethics Committee (ref:09/H0810/16
date: 08/04/2009) and the Ethics and Confidentiality Committee
(ECC) (ref: ECC 2-06(b)/2009 CALIBER dataset). CALIBER has
been registered with the University College London Data
Protection Officer (ref: Z6364106/2009/2/26). CALIBER EHR
data are anonymized; individual informed consent was not sought
from study participants.
Inclusion criteria were: age greater than 30, minimum one year
of validated data prior to entry, and registration at a primary care
provider with up-to-standard data. This defined a base cohort of
2,128,151 individuals in which to identify AF. Exclusion criteria
were any records of AF diagnosis prior to cohort entry, or the first
record of AF after entry being a term indicating monitoring of
existing AF or a historical diagnosis of AF. Patients were included
and followed-up from the date they met all inclusion criteria or
January 1st, 1998, whichever was later. Follow-up ended on: the
first of the administrative censoring date for primary care data
(March 26th, 2010); last data collection date for a particular
primary care provider; a patient leaving their primary care
provider; or patient death as recorded in ONS. Risk factor
analyses excluded patients with missing data for blood pressure
(BP) measurements, body mass index (BMI), ethnicity or index of
multiple deprivation score.
Strategy for EHR phenotype development
The CALIBER approach to EHR phenotype development
iteratively cycles between expert discussion, review of codes and
their semantic relations, and analysis of data (see Figure 1). An
initial case definition listing codes, or combinations of codes,
indicating diagnosis of a condition is drafted based on discussion
with experts in the clinical phenotype, epidemiology, computer
science, and bioinformatics. For AF, this preliminary definition
only included diagnosis codes directly related to AF from primary
or secondary care (extraction of data from free text or image
processing is currently limited), but we also identified codes for
medications and procedures used in AF treatment for further
investigation (lists of all identified codes are available online on the
CALIBER Data Portal at www.caliberresearch.org).
Initial examination of code usage. A test data set of
100,000 patients was used to investigate how frequently codes
were used in practice, and the relationship between diagnosis
codes and those for medications and procedures. We found, as
have others [53], that although codes for AF subtypes exist within
the Read system, they are infrequently used and most patients
simply have an all-encompassing diagnosis of AF recorded. Codes
indicating an existing condition (e.g. when taking a new patient’s
history) and monitoring of AF are used, but the main codes
recorded relate to a diagnosis of AF. We examined procedure and
prescription codes to see if they could assist in identifying
additional cases. For procedure codes, the overall frequency was
low and they were almost always recorded for patients with a pre-
existing AF diagnosis. However, many patients had prescription
records for warfarin or digoxin (medications used almost
exclusively to treat AF during the time frame of the available
data), but no AF diagnosis code.
Review of these results by the expert group led to three
decisions: (i) due to the infrequent coding of AF subtypes in
primary care, and the single ICD-10 code in secondary care, we
should develop an AF phenotype algorithm combining all
subtypes; (ii) the case definition should not include procedure
codes; (iii) where AF-related prescriptions were made without
recorded diagnoses, we should investigate whether a diagnosis of
AF could be reasonably inferred. To pursue the latter aim, we
developed case definitions based on clinical knowledge of
treatment patterns strongly indicative of AF; warfarin prescriptions
in the absence of prior deep vein thrombosis (DVT) or pulmonary
embolism (PE), or digoxin prescriptions in the absence of heart
failure (HF) were taken as evidence to support an ‘‘inferred’’
diagnosis of AF. These conditions were identified using previously
defined CALIBER phenotype algorithms for DVT, PE, and HF
(see CALIBER Data Portal at www.caliberresearch.org for
details).
Exploration of the EHR
Refining disease onset. We investigated the time elapsed
between incident AF diagnoses recorded using ICD-10 or Read
codes in multiple data sources to see if combing data improved
estimation of disease onset. We also investigated the utility of
further refining onset using an indicator marker (irregular pulse),
examining the frequency of these codes and the time that elapsed
between the relevant code(s) being recorded and a subsequent
coded diagnosis of AF.
Disease case identification. We investigated whether com-
bining multiple sources of EHR data increased the overall number
of disease cases identified by permitting us to infer AF diagnoses on
the basis of patterns of medication use and comorbid conditions.
Characteristics of diagnosed patients
As the phenotype algorithm we developed was used to identify
diagnoses from different data sources over an extended time
period, we wanted to explore whether there were context-level
and/or patient-level differences in the cases identified. We
quantified the unique and non-unique AF cases identified in each
source. We then investigated the relationship between the data
source and (i) diagnosis context, specifically the year of diagnosis
and whether AF was the primary or secondary reason for
admission for secondary care diagnoses (HES provides up 15
secondary diagnosis codes); and (ii) individual patient character-
istics at diagnosis including sex, age, and important comorbid
conditions (HF, myocardial infarction, hypertension, stroke,
diabetes, thyroid disease, renal failure, and chronic obstructive
pulmonary disease).
Association with known risk factors
The face validity of the CALIBER AF phenotype was evaluated
by conducting a pre-specified analysis of the association between
AF diagnosis and factors for which there is strong prior evidence of
Defining Disease Phenotypes Using Linked Electronic Health Records
PLOS ONE | www.plosone.org 3 November 2014 | Volume 9 | Issue 11 | e110900
association with AF diagnosis from both clinical observations and
multiple epidemiological studies: HF, hypertension, and myocar-
dial infarction (MI) [11]. Cause specific Cox proportional hazards
models were used to estimate hazard ratio and 95% confidence
intervals for incident AF diagnosis associated with baseline
measures of risk factors, adjusted for age, sex, and primary care
practice [54,55]. All analyses excluded patients diagnosed with AF
prior to study baseline. All statistical analyses were conducted in R
version 15.2 for Mac and Linux [56].
Results
Sample characteristics
We identified 24 codes (23 Read codes and one ICD-10 code)
relating to AF diagnosis. Ten codes refer to monitoring of pre-
existing AF, three confirm a prior diagnosis of AF, and the
remaining 11 indicate diagnosis by a current care provider. The
CALIBER cohort of 2,128,151 participants included 33,383
individuals with an AF code in their record indicating diagnosis
prior to cohort entry. Thus, at baseline, approximately 1.6% of the
sample had already received a diagnosis of AF, which is similar to
prevalence estimate of 2.0% (95% C.I. 1.6–2.4%) provided by the
recent UK-based general population ECHOES study [57]. Of the
remaining 2,094,768 patients without an AF diagnosis at baseline,
72,793 received their first recorded AF diagnosis code during the
study period. A total of 22,939 (45.2%) of patients were initially
diagnosed in primary care, with the remaining 39,863 (54.8%)
initially diagnosed in secondary care (those diagnosed on the same
date in two sources were attributed to secondary care).
Exploration of the EHR
Refining disease onset: Timeframe for diagnosis. To
investigate whether combining data from primary and secondary
care improved resolution of disease onset, we examined the data
for 28,795 individuals with incident diagnoses recorded in both
primary and secondary care. The time elapsed between AF
diagnoses in the two sources depended on the source of the initial
diagnosis. An AF diagnosis was first recorded in primary care for
13,707 individuals, and in secondary care for 10,380 individuals
(for 4,708 individuals the dates were the same). The median time
from primary care diagnosis to secondary care diagnosis was just
over one year (367.0 days), while the mean was almost two years
(724.4 days). In contrast, the median time from secondary to
primary care AF diagnosis was 20 days (mean 212.6 days).
Refining disease onset: Irregular pulse. The primary care
Read code system includes five codes for pulse palpation: two
indicate a normal or ‘‘regular’’ pulse, and three indicate an
‘‘irregular’’ pulse. Only 1,252 (1.78%) of the 72,793 participants
Figure 1. Illustration of phenotype algorithm developing using the Clinical Research Using Linked Bespoke Studies and Electronic
health records (CALIBER) programme. CPRD represents the Clinical Practice Research Data link; HES represents Hospital Episode Statistics;
MINAP is the Myocardial Ischaemia National Audit Registry; ONS is the UK Office of National Statistics (mortality and social deprivation data).
doi:10.1371/journal.pone.0110900.g001
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with an incident AF diagnosis had any pulse palpation recorded
between study entry and AF diagnosis, with irregular pulse the
record closest to AF diagnosis for 964 patients (77.1% of those with
any pulse palpation recorded). The median time from first
irregular pulse to AF diagnosis in patients where both were
recorded after study entry was 71 days. Less than half (40.1%) of
patients were diagnosed with AF by 30 days after the irregular
pulse code, with 65.8% diagnosed by 12 months.
Disease case identification: Inferred diagnosis. Inferred
diagnoses were identified based on a combination of 262 codes: 63
relating to prescriptions (36 for warfarin, 27 for digoxin) and 199
excluding conditions (97 for prior HF, 60 for prior DVT, 22 for
prior PE) and procedures (20 for heart valve replacement). A total
of 39,527 patients met the criteria for an inferred diagnosis of AF
during the study period. Warfarin prescriptions accounted for
18,714 (47%) patient diagnoses, digoxin prescriptions for 10,592
(28%), and the remaining 10,221 (26%) had both prescription
patterns. A small percentage of patients with an inferred diagnosis
(3,754; 9.5%) received coded or historical diagnoses of AF prior to
cohort entry. Of the remaining 35,773 individuals, 28,305 (71.6%)
had an AF diagnosis code recorded during follow-up and 7,468
(18.9%) had no codes relating to AF diagnosis in their record.
Of the 28,305 individuals who met the inferred AF diagnosis
criteria and had an AF diagnosis code within the study window,
the majority (75.7%; 21,420 individuals) received the diagnosis
code before meeting the criteria for an inferred diagnosis, and for a
further 11.2% (3,167 individuals) this occurred on the same day.
Thus only 13% of patients (3,718 individuals) met the inferred
diagnosis criteria before an AF diagnosis was recorded. For these
3,718 individuals, the average time between an inferred diagnosis
and receiving a diagnosis code was 19.8 months (median 6.54
months). Within 30 days of meeting inferred diagnosis criteria,
21.1% of these patients received a diagnosis code; 59.7% received
a diagnosis code within one year. However, the temporal
relationship between these diagnoses varied depending on the
year of the initial inferred diagnosis; the proportion receiving a
diagnosis code within 12 months increased gradually over time
from 37.1% in 1998 to 92.3% in 2009. The proportion of AF cases
based on inferred criteria also decreased over the study period,
from just over 15% of cases in 1998 to less than 10% of cases from
2006 onwards.
EHR phenotype algorithm
The results above informed the development of the AF
phenotype algorithm in two ways. First, as pulse palpation was
only recorded for a small minority of patients we concluded it did
not provide enough additional information to warrant inclusion in
our current AF case definition. Second, although examining the
pattern of treatments and co-existing conditions did identify
additional disease cases, without additional information (e.g.
review of free text) we could not confidently conclude that patients
without a recorded AF diagnosis code should be considered as
cases, or that medication prescriptions represent a diagnosis date.
Consequently, we included individuals with only an inferred
diagnosis in our EHR case definition as a separate category, and
used date of recoded AF diagnosis code in preference to date of
meeting inferred criteria.
The case definition for AF using the phenotype algorithm thus
had three categories:
1. Historical: first recorded AF code indicates monitoring of an
existing condition, or reference to a previous AF diagnosis.
2. Diagnosed: first record is a diagnosis code for AF; preference
given to the earliest dated record rather than diagnosis source
(i.e. no preference for primary versus secondary care).
3. Inferred: no diagnosis code is present, but the patient record
includes a warfarin prescription in the absence of prior DVT or
PE, or a digoxin prescription in the absence of HF.
The phenotype algorithm incorporates these definitions in a
hierarchical, mutually exclusive manner (see Figure 2). If the
earliest recorded AF codes relate to a historical diagnosis or
monitoring, the patient is in category 1 which precludes inclusion
in other categories. If these codes are absent, then the presence of
a coded diagnosis from primary or secondary care places a patient
in category 2. Finally, in the absence of a coded diagnosis, a
patient may be allocated to category 3, depending on the
combination of prescriptions and diagnoses in their record.
Otherwise a participant is treated as undiagnosed.
Characteristics of diagnosed patients
Using the phenotype algorithm we identified 80,261 individuals
with an incident coded or inferred AF diagnosis in the CALIBER
cohort. Of these, 7,468 had no diagnosis code but met the inferred
diagnosis criteria. Almost half the patients with a diagnosis code
(39.6%; 28,795 individuals) had diagnoses recorded in both
primary and secondary care (see Figure 3). All sources provided
unique diagnoses, but substantially more were identified from
secondary care, which provided almost three times the number of
unique cases (32,930 cases compared to 11,068 from primary
care). The proportion of AF cases identified in primary care or by
inferred diagnosis decreased by year of diagnosis, whereas the
proportion identified in secondary care increased, but no threshold
effect was identified around the introduction of the QOF in 2004.
The proportion of cases contributed by each source differed by
age at diagnosis; individuals identified by inferred diagnosis
criteria made up a greater proportion of cases diagnosed at
younger ages (#60 years), while cases diagnosed at older ages ($
80 years) were mostly identified from secondary care data (see
Figure 4). The proportion of cases identified in primary care was
highest for ages 60–80 years, but for all age groups primary care
contributed fewer cases than secondary care. For patients
diagnosed in secondary care, AF was more likely to be the main
diagnosis for the hospital episode when individuals were younger
(#50 years), whereas amongst those diagnosed at older ages AF
was much more likely to be a secondary diagnosis made during
admission for another condition. Patients with diagnoses recorded
only in secondary care were slightly more likely to be female
compared to those with diagnoses in both data sources, primary
care only, or inferred diagnoses (51.3%, 48.2%, 48.8% and 47.6%
female respectively).
The percentage of patients with comorbid conditions at the time
that their AF diagnosis was recorded differed by source of
diagnosis (see Table 1). Patients for which an AF diagnosis was
drawn only from secondary care were more likely to have already
received a diagnosis for all the conditions examined, with the
exception of hypertension, than those with a diagnosis drawn from
primary care or meeting the inferred diagnosis criteria. The
difference between data sources was largest for renal failure; the
percentage of patients with renal failure amongst those diagnosed
with AF in secondary care only was twice that of patients with AF
diagnoses recorded in the other data sources (22.4% versus 10.9%,
11.0%, and 10.0%). A similar, although less extreme, pattern was
also observed for HF, MI, stroke, and diabetes (Type 2). This does
not appear to be completely due to differences in the age of
patients from each source as even within age groups the
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percentages of patients with pre-existing conditions were still
higher for those diagnosed in secondary care, particularly for HF
and diabetes. In contrast, the percentage of AF patients with
hypertension was highest amongst those with a primary care
diagnosis (86.0% for primary and secondary, 86.2% for primary
only, compared to 83% for secondary only and 78% for inferred).
Associations with known risk factors
The associations between pre-specified risk factors and incident
AF were consistent in magnitude across EHR sources and with
estimates from traditional consented cohorts (see Figure 5 and
Table S1). For HF, the hazard ratio estimate was 2.07 (95% CI
1.95–2.19) using only primary care data for AF diagnosis, 2.31
(2.21–2.43) for secondary care data only, and 2.35 (2.25–2.46) for
both sources combined (an inferred diagnosis could not be used for
the HF analysis as this diagnosis is incorporated into the case
definition). For hypertension, the hazard ratio estimates were 1.74
(95% CI 1.70–1.78) for primary care only, 1.80 (1.76–1.84) for
secondary care only, 1.72 (1.68–1.77) for inferred diagnoses, and
1.80 (1.77–1.84) for the composite endpoint. The hazard ratio
estimates for MI were 1.53 (1.46–1.60) for primary care only, 1.75
(1.68–1.82) for secondary care only, 1.69 (1.61–1.77) for inferred
diagnoses, and 1.70 (1.64–1.76) for the composite endpoint.
The estimates for hypertension and MI were comparable to age
and sex adjusted results from traditional cohort studies such as the
Framingham Heart Study [58] (HR 1.80, 95% C.I. 1.48–2.18 for
hypertension; HR 1.44, 95% C.I. 1.02–2.03 for MI) as well as
those from the other EHR studies (see Table S1). The estimates
for heart failure were towards the lower bound of those obtained
from the Framingham Heart Study (HR 3.2, 95% C.I. 1.99–5.16)
and EHR studies.
Discussion
We explored the characteristics of the information recorded
around the diagnosis of a chronic condition, AF, in multiple linked
data sources for a cohort of 2,128,151 individuals from the general
population. This exploration highlighted a number of key findings
with implications for EHR research on AF, and on chronic
conditions more broadly. We found that: (i) refining the timing of
disease onset can potentially be improved by the clinically-
informed use of data that goes beyond diagnosis codes for the
condition in question, but what is recorded as part of routine
clinical practice may differ substantially from clinical guidelines; (ii)
integrating data from multiple EHR sources and administrative
data does improve case detection; (iii) the context in which data
are collected may have an impact on the characteristics of the
disease cases identified. We used this information to develop an
EHR phenotype for identifying AF disease cases that was informed
Figure 2. Flow diagram illustrating CALIBER phenotype for atrial fibrillation.
doi:10.1371/journal.pone.0110900.g002
Figure 3. Euler diagram displaying the number of incident
cases identified in the different sources, including overlap
between multiple sources.
doi:10.1371/journal.pone.0110900.g003
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by an understanding of the patient record, and evaluated the face
validity of it using epidemiological analyses.
Combining data from multiple sources to identify AF cases
helped to refine estimates of disease onset in this sample. Using
primary care data brought the date of diagnosis forward by one to
two years for patients subsequently diagnosed in secondary care.
Although there was a slight lag (median 20 days) from a diagnosis
being recorded in secondary care to it being recorded in primary
care, this more likely indicates a delay in transfer of diagnosis
information from hospital to general practitioner than separate
diagnoses. Pulse palpation records were investigated because this is
recommended as a screening test for AF in primary care [11,14].
In our cohort, very few AF patients (just over 2%) had a record of
pulse palpation prior to diagnosis and therefore these data had
limited use for refining disease onset and were not incorporated
into the phenotype algorithm. This underlines the importance of
Figure 4. Proportion of incident atrial fibrillation cases identified in each source by age at diagnosis.
doi:10.1371/journal.pone.0110900.g004
Table 1. Percentage of patients with different comorbid conditions at date of atrial fibrillation diagnosis, by source of diagnosis.
Characteristic Category Source of diagnosis
Secondary only
(N=32930)
Primary and secondary
(N=28795)
Primary only
(N=11068) Inferred (N=7468)
HF 18.8 15.1 12.7 8.5
MI 13.2 10.0 8.3 14.1
Stroke 9.2 6.0 6.2 8.7
Diabetes Type 1 0.62 0.39 0.49 0.90
Type 2 14.73 10.79 9.40 9.53
NOS 1.76 1.13 1.38 1.94
Hypertension 83.0 86.0 86.2 78.0
Thyroid disease Hyper 1.7 1.5 1.6 1.0
Hypo 8.5 7.1 6.8 5.6
Renal failure 22.4 10.9 11.0 10.0
COPD 46.9 44.7 40.9 38.7
Practice Research HF indicates heart failure, MI indicates myocardial infarction, COPD indicates chronic obstructive pulmonary disease, NOS indicates not otherwise
specified. Note that some conditions may have been recorded on the same date as the atrial fibrillation diagnosis.
doi:10.1371/journal.pone.0110900.t001
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understanding the EHR; a phenotype algorithm for AF based only
on clinical guidelines could have required pulse palpation prior to
diagnosis and would have excluded the vast majority of cases
drawn from primary care data. However, Nicholson et al., [2]
found that ‘‘indicator markers’’ for rheumatoid arthritis in primary
care, such as joint signs and symptoms or non-steroidal anti-
inflammatory drug prescriptions, were potentially informative so
the utility of ‘‘indicator markers’’ and screening tests should be
evaluated on a disease-by-disease basis, and may inform further
quality of care research as well as EHR research.
Integrating data from multiple sources identified more AF cases
than examining any single source, as has been demonstrated for
other cardiovascular conditions [7,59]. This was primarily due to
the fact that a substantial percentage of cases were unique to each
data source (13.8% from primary care, 41.0% from secondary
care), but integrating data from both sources to infer diagnoses
also identified unique cases (9.3%). This demonstrates that
clinically informed combinations of treatment records and
diagnoses of other conditions can be useful for interrogating
EHR datasets, although this may not be true for all conditions in
all contexts. For example, Pascoe et al. [60] found that procedure
codes (such as mastectomy) and prescriptions (such as tamoxifen)
could be combined to improve identification of cancer cases in UK
EHR data, but we found that procedure codes (such as direct
current cardioversion) did not improve AF case detection because
they were almost exclusively recorded in patients with a pre-
existing AF diagnosis. Additionally, coding combinations could be
so complex for some conditions that this approach is infeasible; the
inferred AF diagnosis incorporated not only medications but also
whether diagnoses were recorded for another condition for which
these medications might be used, namely HF, DVT, and PE. The
CALIBER programme facilitated this as case definitions and
associated EHR phenotypes had already been developed for these
conditions; without access to a resource such as this, use of
treatment and/or comorbidity information could be substantially
more onerous.
The AF patients we identified differed by data source in regard
to age, sex, and comorbid conditions, and also over time. Patients
identified in secondary care were comparatively older than those
identified in primary care, and in many cases AF was a secondary
diagnosis made when the patient was admitted for another
condition. These patients were also more likely to have a comorbid
diagnosis for another condition such as HF, renal failure, or
diabetes. Focusing on only one source of data could, therefore,
give misleading results about the age distribution and relative
health of the AF patient population; integrating data from multiple
sources is important for obtaining a representative sample.
Ignoring the temporal context of EHR data could also misrepre-
sent the sample and present challenges for phenotyping. We
found, as have others (e.g. [61]), that the impact of clinical
guidelines can be investigated using EHR data. In our sample, the
proportion of inferred AF cases decreased over the study period, as
did the time between meeting the inferred criteria and receiving an
AF diagnosis code. This gradual change in diagnostic and coding
practices may be due to increasing awareness of AF as a condition
warranting specific treatment, and potentially the inclusion in the
QOF from 2004, although we did not observe a sharp alteration
around this time point. This has broader implications for
identification of disease cases in EHR data, particularly where
treatment information is incorporated; case definitions and
phenotype algorithms may need to allow for temporal changes
in clinical practice and recording, and not rely on a single strategy
being equally effective for all time points.
Limitations
The work described here has three major limitations relating to
the data sources available for use, the strategy used for the AF case
definition, and the capacity for external validation. Currently our
phenotype algorithm does not use natural language processing
(NLP) or imaging data. Use of non-coded data via NLP has been
shown to improve detection of other cardiovascular conditions
that are difficult to diagnose, such as angina pectoris [62], but
although work in this area for application to CALIBER data is
ongoing [63,64], it is not currently ready for general use. Ideally,
AF cases identified in EHR data would be confirmed by
electrocardiogram readings that displayed variability in the R-R
intervals [14], but this source of data is also not currently available
on a national scale.
As our aim was to develop an AF phenotype that was of use to
all researchers using EHR data, regardless of computational
resources, we did not employ some of the more sophisticated
techniques used in some other EHR phenotyping studies. We
interpreted the first diagnosis code in a patient record as a
confirmed diagnosis, but in other EHR phenotypes researchers
have required multiple diagnosis codes (e.g. [65]), or used more
complex analytical methods (e.g. [66]). These strategies are
undoubtedly useful for EHR phenotyping, particularly if the
probability of false diagnoses is high, but this will be disease- and
context-specific. In the case of AF in the UK during the time
period considered, under-diagnosis is the more likely clinical
scenario [16,17], and thus we deemed one AF diagnosis code
sufficient. The inferred AF case definition was developed to
capture some patients without a recorded diagnosis, but of course
this cannot capture patients for whom no AF-related codes were
recorded.
An important aspect of EHR phenotype development is
validation, preferably against a ‘‘gold standard’’ (such as a manual
review of case notes). We could not validate the AF phenotype in
this manner as for the CALIBER programme, the initiation and
funding of a separate study is required for re-contacting
Figure 5. Hazard ratio estimates and 95% confidence intervals
for pre-specified risk factors of interest. Results are shown
separately for associations between each risk factor and incident AF,
defined according to each source of cases and for a composite using all
sources. All analyses were adjusted for age, sex, and practice ID. Note
that the use of heart failure diagnosis in the algorithm for inferred AF
precludes estimation of the hazard ratio. The dashed lines are point
estimates of hazard ratios from the Framingham Heart Study for the
same risk factors, adjusted for age and sex (see reference [58]).
doi:10.1371/journal.pone.0110900.g005
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participants or clinicians to confirm diagnoses or review records.
However, previous research has shown that AF diagnoses
recorded in NHS primary care have a high degree of reliability
even when relying on a single diagnosis code [24], although similar
information is not available for secondary care (particularly when
AF is not the primary diagnosis). The inferred diagnosis category
also requires further validation work, particularly as it incorporates
information on multiple diagnoses which may have their own
limitations (for example, some HF patients will inadvertently be
classified as AF patients if the sensitivity of HF diagnoses is less
than perfect). In the near future we will apply CALIBER
phenotype algorithms to data from the UK Biobank resource,
which provides scope for validation of EHR phenotypes against
self-reported data and clinical notes [67]. In the absence of
external confirmation of AF diagnoses, we evaluated our
phenotype definition by conducting epidemiological analyses of
the association between known risk factors for AF onset and
disease diagnosis in the CALIBER data set, and comparing our
estimates to those from other studies. Our point estimates for the
hazard ratios for AF and HF, hypertension, and MI were in the
same direction as those obtained from comparable analyses in
both traditional cohort [58,68] and EHR studies [26,31], which
suggests that our AF identification strategy indexes a similar AF
patient population.
Future research
The AF phenotype we have developed has been primarily
informed by clinical understanding and interpretation of the EHR
data. However, research on EHR phenotypes for other conditions
has shown that data-driven approaches, such as using lagged linear
correlations, can inform the EHR phenotyping process and
facilitate the identification of patient subgroupings [4,69]. Once
more sources of data, such as electrocardiogram results and
clinical notes, are available on a national scale such approaches
may prove useful for improved identification (especially refining
the inferred diagnosis category) and further classification of AF
patients.
Conclusion
Overall, we have developed a transparent and reproducible
method for identifying AF cases in data from linked EHR sources
that detects more cases than using a single data source. We have
also highlighted the importance of exploring the patient record
prior to developing EHR phenotype algorithms, including a
number of challenges that may be encountered and potential
strategies for overcoming them. Development of CALIBER
phenotype algorithms is an ongoing, iterative process involving
researchers within, and outside, the CALIBER network. To
facilitate this, the code lists, case definitions, and algorithm for AF
are freely available via from the CALIBER website (www.
caliberresearch.org), and we encourage feedback from those who
make use of this, and other, CALIBER phenotype algorithms.
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